Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025

Rhea-AI Summary

Lexicon Pharmaceuticals (Nasdaq: LXRX) has announced its upcoming participation in the Leerink Partners Global Healthcare Conference 2025 in Miami. The company's management will engage in a fireside chat scheduled for Wednesday, March 12, at 10:00 a.m. ET. Both the live presentation and a subsequent replay will be made available to interested parties through the Events section of Lexicon's investor relations website at investors.lexpharma.com.

News Market Reaction – LXRX

+6.55%

+6.55% Session move

In the trading session that priced this news, LXRX gained 6.55%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 in Miami on Wednesday, March 12, at 10:00 a.m. ET.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals 
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com. 

For Investor and Media Inquiries: 
Lisa DeFrancesco  
Lexicon Pharmaceuticals, Inc. 
lexinvest@lexpharma.com 

FAQ

When is Lexicon Pharmaceuticals (LXRX) presenting at the Leerink Partners Conference 2025?

Lexicon Pharmaceuticals will present on Wednesday, March 12, 2025, at 10:00 a.m. ET in Miami.

How can investors access LXRX's Leerink Partners Conference 2025 presentation?

Investors can access both the live event and replay through Lexicon's investor website at investors.lexpharma.com/Events.

What type of presentation will LXRX deliver at the Leerink Partners Healthcare Conference?

Lexicon Pharmaceuticals will participate in a fireside chat format presentation.

Where is the Leerink Partners Global Healthcare Conference 2025 being held?

The conference is being held in Miami.